Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Huarong International Financial | Hong Kong | Financial | Investment Banking & Investment Services | HKD 2.13B | -5.2x | -0.07 | HKD 0.25 | 17.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Capital VC | Hong Kong | Financial | Investment Banking & Investment Services | HKD 114.78M | -1.4x | -0.07 | HKD 0.25 | 8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ARTA TechFin | Hong Kong | Financial | Investment Banking & Investment Services | HKD 861.44M | -14.7x | -0.44 | HKD 0.05 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gaoyu Finance | Hong Kong | Financial | Banking Services | HKD 116.62M | 12.3x | 0.06 | HKD 0.05 | 14% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Beigene | Hong Kong | Healthcare | Biotechnology & Medical Research | HKD 13.54B | -3.3x | -0.69 | HKD 127.50 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Ascentage Pharma | Hong Kong | Healthcare | Biotechnology & Medical Research | HKD 14.37B | -29.7x | -0.53 | HKD 46.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -17.3% Downside | Upgrade to Pro+ | |
Gome Finance Tech | Hong Kong | Financial | Banking Services | HKD 1.66B | 16x | 0.03 | HKD 0.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Trip.com Group | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HKD 300.92B | 16.1x | 0.18 | HKD 469.40 | 3.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Yinsheng Digifavor | Hong Kong | Technology | Telecommunications Services | HKD 1.23B | 30.5x | 0.15 | HKD 2.97 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Everest Med | Hong Kong | Healthcare | Pharmaceuticals | HKD 2.44B | -6.2x | HKD 25.60 | 8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Fengyinhe Holdings | Hong Kong | Financial | Investment Banking & Investment Services | HKD 144.17M | 0.9x | -0.08 | HKD 0.43 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sands China | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HKD 148.43B | 18x | 0.07 | HKD 18.34 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.5% Upside | Upgrade to Pro+ | |
DT Capital | Hong Kong | Financial | Investment Holding Companies | HKD 186M | -22.7x | -0.37 | HKD 0.07 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Galaxy Entertainment Group | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HKD 148.82B | 17.9x | 0.01 | HKD 34.05 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.9% Upside | Upgrade to Pro+ | |
China Graphene | Hong Kong | Real Estate | Real Estate Operations | HKD 546.33M | 28.7x | 0.58 | HKD 0.09 | 7.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunwah Kingsway Capital | Hong Kong | Financial | Investment Banking & Investment Services | HKD 165.28M | -2.9x | -0.11 | HKD 0.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zhaoke Ophthalmology | Hong Kong | Healthcare | Pharmaceuticals | HKD 759.13M | -3.1x | -0.06 | HKD 1.37 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abbisko Cayman | Hong Kong | Healthcare | Biotechnology & Medical Research | HKD 2.21B | -121.8x | -1.25 | HKD 3.86 | 9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
China Merchants China Direct | Hong Kong | Financial | Investment Banking & Investment Services | HKD 2.32B | 198.7x | 1.74 | HKD 15.26 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
AUSupreme Intl | Hong Kong | Consumer Cyclicals | Specialty Retailers | HKD 175.26M | 5.8x | 0 | HKD 0.23 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dynamic | Hong Kong | Real Estate | Real Estate Operations | HKD 1.81B | 0.3x | 0 | HKD 7.60 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mabpharm | Hong Kong | Healthcare | Biotechnology & Medical Research | HKD 1.53B | -5.9x | 0.95 | HKD 0.37 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orient Securities Int | Hong Kong | Financial | Banking Services | HKD 19.49M | 6.9x | 0.07 | HKD 0.19 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hopefluent | Hong Kong | Real Estate | Real Estate Operations | HKD 391.01M | -1x | 0.01 | HKD 0.63 | 8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LFG Investment Holdings | Hong Kong | Financial | Investment Banking & Investment Services | HKD 81.19M | -19.4x | -0.23 | HKD 0.20 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Wealthink AI Innovation Capital | Hong Kong | Financial | Investment Banking & Investment Services | HKD 967.87M | 18.4x | -0.27 | HKD 0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Melco Int Development | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HKD 7.45B | -5.9x | -0.1 | HKD 4.91 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.1% Upside | Upgrade to Pro+ | |
Remegen | Hong Kong | Healthcare | Biotechnology & Medical Research | HKD 14.28B | -3.3x | 0.26 | HKD 14.72 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Safety Godown | Hong Kong | Real Estate | Real Estate Operations | HKD 765.45M | -6.2x | -0.18 | HKD 1.89 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MGM China Holdings | Hong Kong | Consumer Cyclicals | Hotels & Entertainment Services | HKD 38.23B | 8.5x | 0.03 | HKD 10.06 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |